Financial Partners Group LLC Boosts Stake in Humana Inc. (NYSE:HUM)

Financial Partners Group LLC raised its stake in shares of Humana Inc. (NYSE:HUM) by 1.3% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 18,591 shares of the insurance provider’s stock after acquiring an additional 241 shares during the quarter. Humana makes up about 2.2% of Financial Partners Group LLC’s portfolio, making the stock its 15th biggest position. Financial Partners Group LLC’s holdings in Humana were worth $5,889,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds have also made changes to their positions in the company. CarsonAllaria Wealth Management Ltd. boosted its position in Humana by 111.4% during the second quarter. CarsonAllaria Wealth Management Ltd. now owns 74 shares of the insurance provider’s stock valued at $28,000 after purchasing an additional 39 shares in the last quarter. Atwood & Palmer Inc. purchased a new stake in shares of Humana during the third quarter valued at about $29,000. Hantz Financial Services Inc. bought a new stake in shares of Humana in the 2nd quarter valued at about $35,000. Family Firm Inc. purchased a new position in shares of Humana in the 2nd quarter worth approximately $37,000. Finally, Hollencrest Capital Management bought a new position in shares of Humana during the 2nd quarter worth approximately $40,000. 92.38% of the stock is currently owned by hedge funds and other institutional investors.

Humana Stock Down 0.1 %

Humana stock opened at $258.41 on Friday. Humana Inc. has a 52 week low of $213.31 and a 52 week high of $527.18. The firm has a market cap of $31.14 billion, a price-to-earnings ratio of 16.09, a price-to-earnings-growth ratio of 1.91 and a beta of 0.50. The business’s 50-day moving average price is $310.28 and its 200 day moving average price is $337.43. The company has a quick ratio of 1.66, a current ratio of 1.66 and a debt-to-equity ratio of 0.70.

Humana (NYSE:HUM) last issued its quarterly earnings data on Wednesday, July 31st. The insurance provider reported $6.96 EPS for the quarter, topping analysts’ consensus estimates of $5.89 by $1.07. Humana had a net margin of 1.53% and a return on equity of 16.12%. The business had revenue of $29.54 billion for the quarter, compared to analysts’ expectations of $28.52 billion. During the same quarter last year, the company earned $8.94 EPS. The business’s revenue was up 10.4% on a year-over-year basis. As a group, sell-side analysts anticipate that Humana Inc. will post 16.06 earnings per share for the current year.

Humana Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, January 31st. Investors of record on Tuesday, December 31st will be issued a $0.885 dividend. This represents a $3.54 dividend on an annualized basis and a yield of 1.37%. Humana’s payout ratio is 22.04%.

Analyst Ratings Changes

HUM has been the subject of several recent analyst reports. Bank of America downgraded shares of Humana from a “neutral” rating to an “underperform” rating and lowered their target price for the company from $376.00 to $247.00 in a research note on Wednesday, October 2nd. TD Cowen cut Humana from a “buy” rating to a “hold” rating and lowered their price objective for the stock from $402.00 to $261.00 in a research report on Monday, October 7th. Sanford C. Bernstein raised Humana from a “market perform” rating to an “outperform” rating and set a $308.00 target price on the stock in a research report on Tuesday, October 8th. Jefferies Financial Group cut Humana from a “buy” rating to a “hold” rating and decreased their price target for the company from $519.00 to $253.00 in a research note on Monday, October 7th. Finally, UBS Group dropped their price target on Humana from $380.00 to $250.00 and set a “neutral” rating on the stock in a research note on Friday, October 4th. One investment analyst has rated the stock with a sell rating, nineteen have assigned a hold rating and six have issued a buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Hold” and an average target price of $315.33.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.